Cronos Group Inc.

AI-generated fair value estimate for this company.

Method: 10-year 2-stage DCF: $70.0M TTM net income base; 10% annual growth years 1-5 (cannabis import/export and U.S. THC beverage expansion); 6% years 6-10; 10% discount rate; 2.5% terminal growth; $465.7M net cash ($467.0M cash less $1.3M debt); 368.41M shares outstanding.

Reasoning: Cronos Group holds an unusually large net cash position (roughly 40% of its market cap) alongside recently improved profitability from international cannabis trade and U.S. hemp-derived THC beverages; valuing normalized earnings growth and then adding back its large net cash balance captures both the operating business and its balance-sheet optionality.